We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
-$290K
Cap. Flow
-$14M
Cap. Flow %
-5.35%
Top 10 Hldgs %
74.48%
Holding
143
New
12
Increased
13
Reduced
10
Closed
30
Avg Time Held
1.4 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
CLOZ icon
Panagram BBB-B CLO ETF
CLOZ
+$15.7M
2
ICLO icon
Invesco AAA CLO Floating Rate Note ETF
ICLO
+$5.87M
3
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$3.12M
4
SNY icon
Sanofi
SNY
+$2.3M
5
CLOX icon
Panagram AAA CLO ETF
CLOX
+$1.96M

Top Sells

Rank Stock Value
1
MDWT
Midwest Holding Inc. Common Stock
MDWT
+$10.2M
2
MITAW icon
Coliseum Acquisition Corp. Warrant
MITAW
+$5.69M
3
FBRT icon
Franklin BSP Realty Trust
FBRT
+$4.34M
4
CLMT icon
Calumet Specialty Products
CLMT
+$4.07M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$3.82M

Sector Composition

Rank Sector Weight
1 Materials 30.32%
2 Healthcare 27.8%
3 Miscellaneous 13.82%
4 Financials 10.28%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CLMT icon
1
Calumet Specialty Products
CLMT
$5.06B
$77.3M 29.54%
4,325,000
-251,000
-5% -$4.07M
2021 Q4
8 quarters
APO icon
2
Apollo Global Management
APO
$67B
$21M 8.01%
225,000
– –
2021 Q4
8 quarters
FTAI icon
3
FTAI Aviation
FTAI
$16.8B
$19.7M 7.54%
425,000
– –
2021 Q4
8 quarters
CLOZ icon
4
Panagram BBB-B CLO ETF
CLOZ
$785M
$19M 7.26%
719,368
+598,336
+494% +$15.7M
2023 Q3
1 quarter
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.2T
$15.8M 6.04%
112,220
– –
2021 Q4
8 quarters
DCGO icon
6
DocGo
DCGO
$26.9M
$10.8M 4.11%
1,925,000
– –
2021 Q4
8 quarters
ARDX icon
7
Ardelyx
ARDX
$824M
$8.56M 3.27%
1,380,000
-120,000
-8% -$538K
2022 Q3
5 quarters
LGND icon
8
Ligand Pharmaceuticals
LGND
$5.88B
$8.21M 3.14%
115,000
– –
2021 Q4
8 quarters
ICLO icon
9
Invesco AAA CLO Floating Rate Note ETF
ICLO
$604M
$7.85M 3%
307,019
+229,642
+297% +$5.87M
2023 Q3
1 quarter
OABI icon
10
OmniAb
OABI
$662M
$6.7M 2.56%
1,086,505
– –
2022 Q4
4 quarters
VKTX icon
11
Viking Therapeutics
VKTX
$3.24B
$5.04M 1.93%
270,822
+85,267
+46% +$1.12M
2021 Q4
8 quarters
JAAA icon
12
Janus Henderson AAA CLO ETF
JAAA
$32.1B
$4.71M 1.8%
93,647
+62,215
+198% +$3.12M
2023 Q3
1 quarter
JPM icon
13
JPMorgan Chase
JPM
$890B
$3.57M 1.36%
20,985
– –
2021 Q4
8 quarters
AVDL
14
DELISTED
Avadel Pharmaceuticals
AVDL
$3.56M 1.36%
251,850
+30,000
+14% +$352K
2021 Q4
8 quarters
MDGL icon
15
Madrigal Pharmaceuticals
MDGL
$10.6B
$3.42M 1.31%
14,800
-200
-1% -$35K
2022 Q3
5 quarters
PFE icon
16
Pfizer
PFE
$166B
$2.81M 1.07%
97,537
– –
2021 Q4
8 quarters
CSX icon
17
CSX Corp
CSX
$89.4B
$2.43M 0.93%
70,000
– –
2022 Q4
4 quarters
GSK icon
18
GSK
GSK
$95.9B
$2.41M 0.92%
65,000
– –
2022 Q3
5 quarters
INZY icon
19
DELISTED
Inozyme Pharma
INZY
$2.4M 0.92%
564,549
+110,541
+24% +$393K
2023 Q1
3 quarters
CLOX icon
20
Panagram AAA CLO ETF
CLOX
$337M
$2.35M 0.9%
92,956
+77,316
+494% +$1.96M
2023 Q3
1 quarter
SNY icon
21
Sanofi
SNY
$95.3B
$2.34M 0.89%
+47,000
New +$2.3M
2023 Q4
0 quarters
CPRX icon
22
DELISTED
Catalyst Pharmaceutical
CPRX
$2.11M 0.81%
+125,450
New +$1.71M
2023 Q4
0 quarters
TVTX icon
23
Travere Therapeutics
TVTX
$5.02B
$1.99M 0.76%
221,005
+120,688
+120% +$879K
2023 Q3
1 quarter
CHRS icon
24
Coherus Oncology
CHRS
$162M
$1.75M 0.67%
526,312
-103,688
-16% -$278K
2023 Q2
2 quarters
CVE icon
25
Cenovus Energy
CVE
$60.2B
$1.58M 0.6%
95,000
– –
2022 Q2
6 quarters
1
2 3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q4 2023 Portfolio in Review

As of Q4 2023, David M. Knott Jr held 143 positions worth $262M, down 0.11% from $262M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

David M. Knott Jr withdrew a net $14M in Q4 2023, closing 30 positions and reducing 10 holdings. Its most notable exit was Midwest Holding Inc. Common Stock, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Materials at 30% of assets, down from 35% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, David M. Knott Jr opened a new position in Sanofi worth $2.34M.

  • David M. Knott Jr's largest Q4 2023 buy was Sanofi: 47,000 shares worth $2.34M.
  • David M. Knott Jr added most to Panagram BBB-B CLO ETF in Q4 2023, an estimated $15.7M increase.
  • David M. Knott Jr's biggest Q4 2023 reduction was Calumet Specialty Products, cutting an estimated $4.07M.
  • David M. Knott Jr fully exited Midwest Holding Inc. Common Stock in Q4 2023, selling an estimated $10.2M.
  • David M. Knott Jr's ten largest holdings make up 74% of its $262M portfolio in Q4 2023.
  • David M. Knott Jr opened 12 new positions and closed 30 in Q4 2023.
  • David M. Knott Jr's portfolio value fell 0.11% quarter-over-quarter to $262M.

Based on David M. Knott Jr's 13F filing for Q4 2023, filed 13 Feb 2024.